FairWarning® Care Provider Customers Lead Expansion of Trust in Electronic Health Records

FairWarningFairWarning, Inc. the inventor, patent holder and world's leading supplier of privacy monitoring solutions for electronic health records announced record growth in the adoption and deployment of the company's solutions.

FairWarning® now has 180 enterprise production customers representing 900 hospitals and over 3,600 clinics, amounting to a 70% growth from 2012 through 2013 year to date. FairWarning® expects that nearly 200 enterprise customers will be in production by year-end 2013.

In the UK, the government has ambitions for a paperless NHS by 2018 and is driving the adoption of electronic patient records and online patient access. The Caldicott2 review acknowledges the need to share information more effectively whilst requiring more transparency around access to patient records. These new market conditions have fuelled the need for the FairWarning® solutions in the NHS.

The company has seen its solution go into production in the first four Scottish Boards in the national roll-out by NHS Scotland. A number of NHS trusts have also gone into production across England and Northern Ireland. These include Cumbria Partnership NHS Foundation Trust, which has selected FairWarning® to strengthen privacy in digital healthcare and emphasise its reputation as a trusted provider of care. Plus Homerton University Hospital NHS Foundation Trust is now successfully deploying the FairWarning® Patient Privacy Monitoring solution across its hospital sites, with plans to roll it out to GP and community.

In Norway, the Health Directorate has selected FairWarning® Patient Privacy Monitoring solution as an integral part of the national roll out of the Norwegian Summary Care Record (SCR). This is due for completion during 2015 and will cover all four regional health authorities with a population of five million.

Other global milestones include:

  • In early 2012, the company launched the FairWarning® Certified Professional training program and has now graduated over 100 privacy monitoring professionals. The company's certified training program has accelerated the availability of experts protecting electronic protected health information (ePHI) and operating privacy monitoring compliance programs. By year end 2013, FairWarning® will have formally trained more than 120 FairWarning® Certified Professionals based on the fully-booked 2013 schedule
  • FairWarning® now maintains over 100 billion audited access events with its 180 production customers. FairWarning® has multiple production customers who have proactively audited and now manage over 5 billion events. The company anticipates continued growth providing FairWarning®'s customers with best-of-class visibility on emerging vulnerabilities in electronic health records
  • In August 2013, The United States Patent Office (USPTO) granted FairWarning® a Notice of Allowance on the company's core privacy monitoring patent. The USPTO Notice of Allowance gives FairWarning®'s customers and partners assurance and trust that the company has a sound basis for its intellectual property rights
  • FairWarning® worked closely with its customers to accomplish the above while increasing its overall KLAS rating. In the midterm report for FairWarning® Privacy Breach Detection, the overall score has risen to 85.7 (out of a 100), an increase of 1% across a 6 month trend. In a recent KLAS Alert released on August 13, 2013, "every customer interviewed said they would purchase FairWarning® again." KLAS Alert about FairWarning® Privacy Breach Detection issued on August 13, 2013. © KLAS Enterprises, LLC.

Care provider customers cite the following as the top market drivers for investing in a FairWarning® solution and participating in FairWarning® Certified Professionals training:

  • The requirement to comply with privacy laws and information governance standards
  • The desire to expand the trust in and scale of their electronic health record investments
  • Awareness that a care provider's reputation for protecting their patients’ confidentiality is a competitive factor in attracting and retaining patients with sensitive medical conditions

According to Kurt Long, CEO and Founder of FairWarning®: "FairWarning® will continue to aggressively invest in additional customer service programs, assuring that care providers are able to grow trust with their patients and confidently expand their electronic health record investments. Further, we are expanding FairWarning® expert service programs that give care providers affordable access to best-in-class compliance and privacy experts as well as providing training to grow their own staff's expertise."

Privacy monitoring benefits to care providers
Leading care providers who are accelerating their deployments of patient privacy monitoring receive the following benefits of their investment:

  • Sustainably comply with complex privacy laws such as HIPAA and the UK Data Protection Act, as well as meeting notification and reporting requirements
  • Ability to confidently scale and grow trust in their electronic health record investments and share medical information electronically with 3rd parties
  • Protect against inadvertent, criminal and fraudulent misuse of electronic health records
  • Grow and protect their reputation for confidentiality, privacy and security
  • Empower confidential sharing of sensitive medical information

About FairWarning, Inc.
FairWarning®'s mission is to lead the industry expansion of trust in Electronic Health Records empowering care providers to grow their reputation for protecting confidentiality, scale their digital health initiatives and comply with complex Federal and state privacy laws such as HIPAA. By partnering with FairWarning, care providers are able to direct their focus on delivering the best patient outcomes possible while receiving expert, sustainable and affordable privacy and compliance solutions. Customers consider FairWarning® privacy auditing solutions essential for compliance with healthcare privacy regulations such as ARRA HITECH privacy and meaningful use criteria, HIPAA, UK and EU Data Protection, California SB 541 and AB 211, Texas HB 300, and Canadian provincial healthcare privacy law.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

Bayer Launches New Healthy-Aging Ecosyst…

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...